• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Nyxoah SA

    5/9/25 4:37:23 PM ET
    $NYXH
    Medical/Dental Instruments
    Health Care
    Get the next $NYXH alert in real time by email
    6-K 1 tm2514680d1_6k.htm FORM 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-40552

     

    NYXOAH SA

    (Translation of registrant’s name into English)

     

    Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium 

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x Form 40-F ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

     

    Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

     

    Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

     

     

     

     

     

    Nyxoah SA

     

    On May 9, 2025, Nyxoah SA (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1.

     

    The information in the attached Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing. 

     

     

     

     

    Exhibits

     

    99.1 Press Release, dated May 9, 2025

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      NYXOAH SA
         
    Date: May 9, 2025 By: /s/ John Landry
      Name: John Landry
      Title: Chief Financial Officer

     

     

     

    Get the next $NYXH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NYXH

    DatePrice TargetRatingAnalyst
    7/31/2023Buy
    H.C. Wainwright
    7/19/2023Neutral
    Robert W. Baird
    4/21/2022$30.00Outperform
    Oppenheimer
    4/6/2022$21.00Peer Perform
    Wolfe Research
    12/21/2021$47.00Overweight
    Cantor Fitzgerald
    7/28/2021$43.00Overweight
    Cantor Fitzgerald
    7/28/2021$40.00Overweight
    Piper Sandler
    7/27/2021$43.00Buy
    Stifel
    More analyst ratings

    $NYXH
    SEC Filings

    See more
    • SEC Form 6-K filed by Nyxoah SA

      6-K - Nyxoah SA (0001857190) (Filer)

      6/27/25 4:30:08 PM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Nyxoah SA

      6-K - Nyxoah SA (0001857190) (Filer)

      5/30/25 5:00:33 PM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Nyxoah SA

      6-K - Nyxoah SA (0001857190) (Filer)

      5/27/25 6:02:42 AM ET
      $NYXH
      Medical/Dental Instruments
      Health Care

    $NYXH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Nyxoah SA

      SC 13D/A - Nyxoah SA (0001857190) (Subject)

      10/10/24 4:00:17 PM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Nyxoah SA (Amendment)

      SC 13D/A - Nyxoah SA (0001857190) (Subject)

      5/30/24 5:20:40 PM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Nyxoah SA (Amendment)

      SC 13G/A - Nyxoah SA (0001857190) (Subject)

      2/14/24 4:17:59 PM ET
      $NYXH
      Medical/Dental Instruments
      Health Care

    $NYXH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • H.C. Wainwright initiated coverage on Nyxoah S.A.

      H.C. Wainwright initiated coverage of Nyxoah S.A. with a rating of Buy

      7/31/23 8:05:01 AM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • Robert W. Baird initiated coverage on Nyxoah S.A.

      Robert W. Baird initiated coverage of Nyxoah S.A. with a rating of Neutral

      7/19/23 7:19:37 AM ET
      $NYXH
      Medical/Dental Instruments
      Health Care
    • Oppenheimer initiated coverage on Nyxoah S.A. with a new price target

      Oppenheimer initiated coverage of Nyxoah S.A. with a rating of Outperform and set a new price target of $30.00

      4/21/22 7:16:59 AM ET
      $NYXH
      Medical/Dental Instruments
      Health Care